MCI Inc. | Jotup

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Globe Life Inc. (GL) Securities Class Action Lawsuit

Retrieved on:

수요일, 5월 15, 2024

Insurance, News, Conduct, Fraud, MCI Inc., AIL, Research, Cendant, AIG, McKesson Corporation, Knowledge, History

PHILADELPHIA, May 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Globe Life Inc. (NYSE: GL) who purchased the stock between May 8, 2019 and April 10, 2024 (the “Class Period”).

Key Points:

PHILADELPHIA, May 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Globe Life Inc. (NYSE: GL) who purchased the stock between May 8, 2019 and April 10, 2024 (the “Class Period”).
If you purchased Globe Life shares during the Class Period and sustained a loss on your investment, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
You may contact the firm at this webpage , or by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
On this news, Globe Life’s share price fell $55.76 per share, or over 53%, to close at $49.17 on April 11, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Globe Life Inc. (GL) Securities Class Action Lawsuit

Retrieved on:

수요일, 5월 8, 2024

News, Insurance, Research, MCI Inc., History, McKesson Corporation, AIL, Conduct, AIG, Cendant, Knowledge, Fraud

PHILADELPHIA, May 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Globe Life Inc. (NYSE: GL) who purchased the stock between May 8, 2019 and April 10, 2024 (the “Class Period”).

Key Points:

PHILADELPHIA, May 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Globe Life Inc. (NYSE: GL) who purchased the stock between May 8, 2019 and April 10, 2024 (the “Class Period”).
If you purchased Globe Life shares during the Class Period and sustained a loss on your investment, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
You may contact the firm at this webpage , or by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
On this news, Globe Life’s share price fell $55.76 per share, or over 53%, to close at $49.17 on April 11, 2024.

Worldcom Public Relations Group Welcomes Two New North America Partners in Baltimore and Rochester

Retrieved on:

목요일, 5월 9, 2024

Marketing, Communications, Digital Marketing, Content Marketing, Media, Public Relations, Investor Relations, Education, Lead, MCI Inc., Counselor, Partnership, Content, PRSA, APR, Trust, Strategic planning

The Worldcom Public Relations Group (Worldcom), the leading global partnership of independent public relations firms, announced today that it has welcomed two new partners to the organization.

Key Points:

The Worldcom Public Relations Group (Worldcom), the leading global partnership of independent public relations firms, announced today that it has welcomed two new partners to the organization.
Abel Communications in Baltimore, Maryland and McDougall Communications, Rochester, NY were recently voted into the partnership.
“For more than 25 years, I’ve had the privilege of collaborating with Worldcom Public Relations Group partners in multiple professional capacities.
“It’s a privilege to join this esteemed group, which will benefit our current and future clients from day one.”
Welcoming these agencies to The Worldcom Public Relations Group marks the completion of a rigorous Worldcom partner recruitment and vetting process.

AscellaHealth Expands Executive Team: Industry Veterans Lead Development and Implementation of End-to-End Payer Solutions and Pharmacy Operations to Control Specialty Spend

Retrieved on:

목요일, 4월 11, 2024

View the full release here: https://www.businesswire.com/news/home/20240411865111/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20240411865111/en/
Bob Gilkin, SVP, AscellaHealth, will design and lead the implementation of trade and specialty strategy positioning.
His strategic leadership will drive the implementation of innovative payer strategies and models, as well as facilitate partnerships with LDD contracts.
We look forward to sharing more information soon.”
Seiden brings the expertise and strategic insights developed during his career in pharmacy operations with experience at BioMatrix Specialty Pharmacy and Elwyn Pharmacy.
This is a key market differentiator that will improve access to LDDs and specialized treatment for health plan members nationwide.”

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on:

월요일, 4월 1, 2024

Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points:

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit

Retrieved on:

수요일, 3월 27, 2024

Cendant, AIG, Patient, History, News, Rett, MCI Inc., McKesson Corporation, Rett syndrome, Complaint, Myenteric plexus, Fraud, Excellence

PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).

Key Points:

PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).
If you purchased Anavex stock during the Class Period and sustained a loss on your investment in these shares, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
You may contact the firm about this matter by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
The complaint alleges Anavex falsely portrayed to investors its research program and the likelihood that its Rett syndrome trials would be successful.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on:

월요일, 3월 25, 2024

Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points:

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on:

수요일, 3월 20, 2024

Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points:

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit

Retrieved on:

월요일, 3월 18, 2024

Cendant, AIG, Patient, History, News, Rett, MCI Inc., McKesson Corporation, Rett syndrome, Complaint, Myenteric plexus, Fraud, Excellence

PHILADELPHIA, March 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).

Key Points:

PHILADELPHIA, March 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).
If you purchased Anavex stock during the Class Period and sustained a loss on your investment in these shares, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
You may contact the firm about this matter by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
The complaint alleges Anavex falsely portrayed to investors its research program and the likelihood that its Rett syndrome trials would be successful.

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

수요일, 2월 28, 2024

MCI Inc., Shareholder, LDD, Investment, Growth, Sale, Annual general meeting, LAL, Patient, Carolwood Pacific Railroad, Video game

Revenue growth was driven by a 52% increase in LDD revenue and a 98% increase in LAL revenue compared to the fourth quarter of 2022.

Key Points:

Revenue growth was driven by a 52% increase in LDD revenue and a 98% increase in LAL revenue compared to the fourth quarter of 2022.
Gross profit for the fourth quarter of 2023 was $17.7 million or 62% of revenue, an increase of $10.2 million or 138% compared to gross profit of $7.4 million or 46% of revenue for the fourth quarter of 2022.
Total operating expenses for the fourth quarter of 2023 were $28.5 million, a 27% increase from $22.4 million in the fourth quarter of 2022, reflecting the company’s ongoing investments to grow its LDD installed base and support increased LAL procedure volumes.
On Wednesday, February 28, 2024, at 1:30 p.m. Pacific Time, the company will host a conference call to discuss its fourth quarter 2023 and full year 2023 financial results.